|Articles|April 19, 2018
Synteract Centers of Therapeutic Development
Advertisement
Synteract, a full-service, Phase I-IV CRO announced the creation of therapeutic centers of development that include oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5